| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210264C 1,3-dialkyl-2-imidazolinones and its prepn. |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/12/2005 | US6916947 Forming 8-aminooctanoic acid hydrochloride by reacting halogenated carboxylic acid ester with metal cyanate and alcohol, then saponifying |
| 07/12/2005 | US6916936 Comprises carbene precursor; by-product inhibition; for chemical waste disposal, plastics recycling; pollution control |
| 07/12/2005 | US6916924 Reacting an aromatic or heteroaromatic carbamate with a heteroarylamine compound to form an intermediate, coupling the intermediate with an electrophile in suitable base and a catalyst |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | US6916347 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/12/2005 | CA2194119C Process for the preparation of 2-substituted 5-chloroimidazole-4-carbaldehydes |
| 07/12/2005 | CA2105867C Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | US20050148645 Improved solubility in organic solvents, facilitating the separation, purification and identification of the components; antimalarial, an antiproliferative agent, an antifungal agent, an antibacterial, or an anti-inflammatory agent |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| 07/07/2005 | US20050148574 Imidazole compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148564 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/07/2005 | US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/06/2005 | EP1550725A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE alpha-METHYLCYSTEINE DERIVATIVE |
| 07/06/2005 | EP1550657A1 Amine compounds and use thereof |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | CN1634895A Imidazole aromatic alcohol derivatives and preparation and use thereof |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914079 Antiproliferative agents; anticancer agents |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | WO2005058842A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | WO2005058840A2 Method of coloring with capped diazotized compound and coupling component |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143575 (Cyclo)condensation of isocyanate compounds |
| 06/30/2005 | US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 06/30/2005 | US20050143437 Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549603A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/29/2005 | EP1548866A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 06/29/2005 | EP1548009A2 Process for the preparation of benzylimidazole derivatives and for losartan |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547598A1 NOVEL USES OF PROSTAGLANDIN D sb 2 /sb , PROSTAGLANDIN D sb 2 /sb AGONIST AND PROSTAGLANDIN D sb 2 /sb ANTAGONIST |
| 06/29/2005 | EP1547590A1 Melanin extinguisher |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546111A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 06/29/2005 | EP1546110A2 Compounds active in sphingosine 1-phosphate signaling |
| 06/29/2005 | EP1546109A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546088A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 06/29/2005 | EP1545483A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/29/2005 | EP1339400B1 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/29/2005 | CN1633417A Imidazolone derivatives for the treatment of viral diseases |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 06/28/2005 | US6911595 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 06/28/2005 | US6911546 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 06/28/2005 | US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/28/2005 | US6911470 Used in treatment of infection by retroviruses such as HIV (HTLV-III/LAV), which causes acquired immuno-deficiency syndrome (AIDS) |
| 06/28/2005 | US6911459 Pharmaceutical composition |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | CA2125679C Novel amino acid derivatives |
| 06/23/2005 | WO2005056537A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005040129A3 Ccr3 receptor antagonists |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | WO2004098625A3 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137197 1H-imidazole derivatives as cannabinoid receptor modulators |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | DE10353673A1 Verfahren zur Reinigung von Climbazol A process for purifying climbazole |
| 06/23/2005 | CA2549355A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | CA2548262A1 Method for the production of tetrahydrogeranylacetone |
| 06/22/2005 | EP1544195A1 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542942A1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542686A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 06/22/2005 | EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |